Role of Alphacalcidol to Reduce Pain and Serum Cartilage Oligomeric Matrix Protein in Elderly with Knee Osteoarthritis
Keywords:Vitamin D, Alphacalcidol, knee OA pain, COMP
Objective : To determine the effect of Alphacalcidol supplementation on pain based on WOMAC pain index and joint cartilage condition based on cartilage oligomeric matrix protein (COMP) serum markers in knee osteoarthritis (OA) elderly patients.
Materials andMethods : This is a randomized, double-blind, and placebo-controlled trial. Symptomatic knee OA elderly subjects visited our clinic in Jakarta July-December 2017 were recruited. History taking, physical examinations, and knee radiology were performed. Serum Vitamin D (25(OH)D) and COMP were analysed using chemiluminescent immunoassay and enzyme-linked immunosorbent assay, respectively. Body mass index, physical activity, sun exposure frequency, and dietary vitamin D were assessed. Subjects were randomly allocated to either intervention group to be given 1 μg Alphacalcidol or control group to be given placebo for 12 weeks. Comparation analysis of WOMAC pain index and serum COMP concentration between both groups was performed.
Results : There were 146 subjects participated this study. Increases of 25(OH)D were found in intervention group (2.63 ±11.24 nmol/L, p=0.05) and control groups (1.09±9.42 nmol/L, p=0.28). Alphacalcidol significantly reduced pain based on WOMAC indicator with mean reduction differences of intervention group compared to control group was 2.174±1.060 (p=0.00). COMP serum level was reduced with mean reduction differences of intervention group compared to control group was 38.15±87.553 ng/ ml (p=0.39). Alphacalcidol and gender were the determinants of WOMAC pain index reduction (p=0.00 and p=0.06, respectively) while Alphacalcidol was the only serum COMP level change determinant (p=0.39).
Conclusions :Alphacalcidol administration reduced pain based on WOMAC indicator and COMP serum in knee OA elderly subjects.
Bangladesh Journal of Medical Science Vol. 21 No. 04 October’22 Page : 759-771
How to Cite
Copyright (c) 2022 Achmad Zaki, Nurhayati Adnan Prihartono, Sudarto Ronoatmodjo, RatnaDjuwita, Sabarinah Prasetyo, Andri MaruliTuaLubis, Rimbawan Rimbawan, Agus Hadian Rahim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.